UFC-Que Choisir calls for a limitation on fee overruns

NEWS

  13/12/2023 | Sophie de Duiéry

 

 
Facebook Twitter Mail Imprimer
 

In France, UFC-Que Choisir, the consumer association, filed an appeal against the government for “inaction” in terms of access to care. She proposes to limit the excess fees of new doctors, citing an “uncontrolled development” of these excesses. She suggests that new doctors choose between a sector without excesses or the Controlled Pricing Practice Option (Optam), which allows limited excesses. She also calls for the elimination of public aid for doctors practicing overspending outside Optam.

The association wants new doctors to no longer have access to “sector 2”, which allows them to charge more than the conventional rate. She supports her criticism with a study showing that the prices of doctors in sector 2 are higher and more homogeneous when there are no longer conventional rate doctors in a geographical area.

According to statistics from the Ministry of Health, 53% of specialists were in sector 2 in 2022, compared to 42% in 2012. On the other hand, only 5% of general practitioners used it in 2022. Optam, spared by the UFC- Que Choisir allows doctors to waive conventional fees for some of their patients.

  Sophie de Duiéry

 WE RECOMMEND YOU

  > The government wants to ease the use of telemedicine.

  >

  > France: the CNAM warns about expensive treatments

  > One in two specialists in excess of fees denounces Que Choisir

  >

 










   
 

Vaping: Anses warns about the long-term risks of electronic cigarettes

 NEWS 

 

 04/02/2026

...

   
   

Pancreatic cancer: promising breakthrough in the laboratory

 NEWS 

 

 03/02/2026

...

   
   

What is the Nipah virus circulating in India?

 NEWS 

 

 28/01/2026

...

   
   

Sommeil : pourquoi faut-il se lever à heures régulières ?

   
   

 09/02/2026

Mpox (Monkeypox): Launch of the Vaccination Campaign in Réunion

 

 RESEARCH 

  03/02/2026

Pancreatic cancer: promising breakthrough in the laboratory

 

 NEWS 

  28/01/2026

What is the Nipah virus circulating in India?

 

 SOCIAL 

  26/01/2026

The government wants to ease the use of telemedicine.

 

 RESEARCH 

  23/01/2026

The life expectancy of the French has increased by 2 years since 2008.

 

 SOCIAL 

  21/01/2026

France: the CNAM warns about expensive treatments

 

 NEWS 

  20/01/2026

Explore ways to preserve your health capital

 

 NEWS 

  19/01/2026

Controversy surrounding an event on unconventional therapies at the Senate

 

 RESEARCH 

  14/01/2026

Pregnancy and Covid: possible impact on neurodevelopment?



   

Contenus sponsorisés


 03/03/2025

Meningitis: a vast vaccination campaign in the Rennes metropolitan area

The Brittany Regional Health Agency (ARS) has announced a large-scale vaccination campaign for 100,000 young people aged 15 to 24 in the Rennes metropolitan area followin

 

 PREVENTION 

  04/02/2025

 

 PREVENTION 

  03/02/2025

 

 PREVENTION 

  21/01/2025

 

 PREVENTION 

  30/12/2024

 

 PREVENTION 

  28/10/2024

Prostate cancer: innovative treatments and diagnostics!

 

 PREVENTION 

  16/10/2024

The air in our homes: a time bomb for our health!

 

 PREVENTION 

  01/10/2024

 

 PREVENTION 

  20/09/2024

Heart failure: the right reflexes to have!



   


     
     







 
     
     
 
 

NOS RADIOS

 

SERVICES

 

THEMATIQUES

 

OUTILS

 

Radio Public Santé
Public Santé Seniors
Public Santé Détente
Public Santé Loisirs & Sports
Public Santé Famille
Public Santé Sexo
Public Santé Nutri-Conso
Public Health Radio
Bien-être Animal
Replay News
Replay News Eco
Replay News Story

 

Frequencies
Replay
Programs
Find
Contact us
Health news
Webradios
Seasonal Diseases

 

Beauty
Nutrition
Family
Hobbies
Prevention
Psychology
Research
Treatments
Sport
Administrative & social
Litterature
Sexology
Animal health

 

Flux RSS
Facebook
X (Twitter)
Linkedin
Newsletters
Services
Journalists
Technical
Press

 

 
 

Rights of reproduction and distribution reserved © Control Channel 2006-2026
Strictly personal use. The user of the site acknowledges having read the usage rights license,
in accept and respect its provisions.

Mentions légales | Conditions générales d'utilisation | Politique de protection des données personnelles | Politique relative aux cookies